Stem cell trial passes first safety test

The first three patients to have stem cells injected into their brains suffered no side-effects and doctors have been given the go-ahead to increase the dosages. 

This means that the therapy can now be tested on more patients. It is hoped that the stem cells will help to repair brain tissue that has been damaged as a result of a stroke.

Dr Sharlin Ahmed, Research Liaison Officer at The Stroke Association says, “When a stroke strikes the brain is starved of oxygen and as a result brain cells in the affected area die. 

“The use of stem cells to replace dead brain tissue is a promising technique which could help to reverse some of the disabling effects of stroke. We are very excited about this trial, however, we are still at the beginning of a very long road and significant further development is needed before stem cell therapy can be regarded as a possible treatment.”

The Stroke Association